11/14/2024
4:45 PM | 5AM Opportunities II, L.P. (Filed by)
Spruce Biosciences (Subject)
| Form SC 13G/A | |
10/28/2024
4:15 PM | Spruce Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
1:26 PM | Rosalind Advisors, Inc. (Filed by)
Spruce Biosciences (Subject)
| Form SC 13G/A | |
08/12/2024
3:18 PM | Spruce Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
3:09 PM | Spruce Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
6:05 AM | Spruce Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
3:05 PM | Spruce Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/25/2024
5:52 PM | Rosalind Advisors, Inc. (Filed by)
Spruce Biosciences (Subject)
| Form SC 13G/A | |
04/05/2024
3:26 PM | Spruce Biosciences (Filer)
| Form ARS | |
04/05/2024
3:12 PM | Spruce Biosciences (Filer)
| Form DEF 14A | |
04/05/2024
3:18 PM | Spruce Biosciences (Filer)
| Form DEFA14A | |
03/28/2024
8:15 PM | Novo Holdings A/S (Filed by)
Spruce Biosciences (Subject)
| Form SC 13D/A | |
03/28/2024
11:42 AM | Radoff Bradley Louis (Filed by)
Spruce Biosciences (Subject)
| Form SC 13G | |
03/25/2024
8:45 PM | Novo Holdings A/S (Reporting)
Spruce Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
8:48 PM | Novo Holdings A/S (Filed by)
Spruce Biosciences (Subject)
| Form SC 13D/A | |
03/20/2024
8:31 PM | Novo Holdings A/S (Filed by)
Spruce Biosciences (Subject)
| Form SC 13D/A | |
03/20/2024
7:56 PM | Novo Holdings A/S (Reporting)
Spruce Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
8:14 PM | Novo Holdings A/S (Reporting)
Spruce Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
8:16 PM | Novo Holdings A/S (Filed by)
Spruce Biosciences (Subject)
| Form SC 13D/A | |
03/18/2024
8:20 PM | Novo Holdings A/S (Reporting)
Spruce Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
3:27 PM | Spruce Biosciences (Issuer)
Szwarcberg Javier B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
3:29 PM | Gharib Samir M. (Reporting)
Spruce Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
3:31 PM | Charlton Ralph William III (Reporting)
Spruce Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:00 PM | Novo Holdings A/S (Reporting)
Spruce Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
3:12 PM | Spruce Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Spruce Biosciences (Subject)
| Form SC 13G/A | |
02/14/2024
1:11 PM | Rock Springs Capital Management LP (Filed by)
Spruce Biosciences (Subject)
| Form SC 13G/A | |
01/30/2024
10:06 AM | Rosalind Advisors, Inc. (Filed by)
Spruce Biosciences (Subject)
| Form SC 13G | |
01/08/2024
7:00 AM | Spruce Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
7:15 PM | Spruce Biosciences (Issuer)
Szwarcberg Javier B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:16 PM | Gharib Samir M. (Reporting)
Spruce Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:17 PM | Charlton Ralph William III (Reporting)
Spruce Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
6:00 PM | Spruce Biosciences (Issuer)
Szwarcberg Javier B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
